LEXINGTON, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq:TTOO) today announced the closing of its initial public offering of 5,980,000 shares of its common stock at an initial public offering price of $11.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 780,000 additional shares of common stock. The shares began trading on the NASDAQ Global Market under the ticker symbol "TTOO" on August 7, 2014. All of the shares in the offering were offered by the company.
Goldman, Sachs & Co. and Morgan Stanley acted as joint book-running managers for the offering. Leerink Partners and Janney Montgomery Scott acted as co-managers. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on August 6, 2014. The offering was made only by means of a written prospectus forming part of the effective registration statement. A copy of the final prospectus related to this offering may be obtained by contacting: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, New York 10282, or by telephone at (866) 471-2526, facsimile at (212) 902-9316, or e-mail at prospectus-ny@ny.email.gs.com, or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by telephone at (866) 718-1649, or e-mail at prospectus@morganstanley.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.